Quebec City, September 9, 2019 – A Quebec company, PurCann Pharma, will gather an impressive list of experts at the Canadian Cannabis Conference to be held on October 10 at the hotel Le Bonne Entente. This will be an opportunity to take stock of the latest advances, the most promising avenues and new uses resulting from scientific research on cannabis. Issues surrounding the cannabis market and project funding will also be addressed.
Participants will be entitled to an analysis of regulatory developments and short-, medium- and long-term prospects for companies in the cannabis market. Knowledge of the day’s progress will also provide a better understanding of the availability of capital, investment levels, lenders’ appetite and their confidence in research prospects.
Renowned speakers will be on hand and participants will meet the experts who are responsible for the growth of the cannabis industry. The complete program of the event, as well as the registration form for this day of exchanges, can be found at www.conferencecannabis.ca. It should be noted that participants will benefit from privileged access to visit the brand new PurCann Pharma plant located in the Quebec City Technology Park.
PurCann Pharma is positioning itself to become a leader in the extraction and purification of molecules derived from hemp and cannabis. The company believes that the future of medical cannabis products leads to higher growth in uses other than recreational in the very short term.
This is why the company is concentrating its efforts on various cannabinoids such as THC and CBD, but also on those with beneficial effects on stress, anxiety, pain, insomnia and certain dermatological conditions. PurCann Pharma’s goal is to obtain pure, high-quality extracts that are free of pesticides and other undesirable molecules. It is in this perspective that the company will inaugurate by the end of 2019 a brand-new plant in Quebec City that will help achieve its goals.
– 30 –